Abstract
Gastric cancer (GC) is one of the prevalent human malignancies and the third most common cause of cancer-related death worldwide. The doxorubicin hydrochloride is one of the important chemotherapeutic anticancer agents, with a limited therapeutic efficacy for treatment of GC. Therefore, taking advantage of synergistic effects by strategies like combination therapy seems appropriate and promising in treatment of GC. The aim of this study was to investigate a novel method to enhance the therapeutic efficacy of doxorubicin (as a chemotherapeutic agent) by co-administration of curcumin (as a bioactive herbal compound) in GC treatment. In the present study, the effects of curcumin, doxorubicin, and their combinations (Dox-Cur) were evaluated on the viability, morphological features, tumor spheroid formation, migration, invasion, and apoptosis of gastric adenocarcinoma cell line (AGS). Moreover, expression levels of BAX, BCL-2, and CASP9 genes were assessed among AGS cells treated with curcumin, doxorubicin, and Dox-Cur. The obtained results showed that all of curcumin, doxorubicin, and Dox-Cur treatments significantly decreased the viability, tumor spheroid formation, migration, and invasion in the GC model cells. Furthermore, apopt...Continue Reading
References
Jul 7, 2005·Postgraduate Medical Journal·M Inoue, S Tsugane
May 9, 2008·Cancer Letters·Preetha AnandBharat B Aggarwal
Dec 27, 2008·Trends in Pharmacological Sciences·Bharat B Aggarwal, Bokyung Sung
Apr 9, 2010·Future Oncology·Dexin Zhang, Daiming Fan
May 6, 2010·JAMA : the Journal of the American Medical Association·William F AndersonCharles S Rabkin
Jun 7, 2011·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Purusotam Basnet, Natasa Skalko-Basnet
Nov 22, 2011·Chinese Journal of Cancer·Takeo Nakanishi, Douglas D Ross
Jan 21, 2014·Biomaterials·Ornchuma NaksuriyaWim E Hennink
Jul 17, 2015·JAMA Oncology·UNKNOWN Global Burden of Disease Cancer CollaborationMohsen Naghavi
Aug 1, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Tayebeh Oghabi BakhshaieshNasser Samadi
Jan 9, 2016·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 25, 2016·International Journal of Molecular Sciences·Ismael RiquelmeJuan Carlos Roa
Aug 30, 2016·World Journal of Gastroenterology : WJG·Tao HuChi Hin Cho
Sep 28, 2016·World Journal of Gastrointestinal Oncology·Wen-Jia Shi, Jin-Bo Gao
Mar 21, 2017·Anticancer Research·Hiroshi SakagamiTakaaki Oizumi
Sep 20, 2017·Journal of Cellular Physiology·Hongbing FuQingping Cai
Feb 3, 2018·International Journal of Molecular Sciences·Claire M Pfeffer, Amareshwar T K Singh
Nov 24, 2018·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Zhenyu XuJing Shen
May 22, 2019·International Journal of Molecular Sciences·Nor Isnida IsmailRakesh Naidu
Citations
Oct 22, 2020·Antioxidants·Riadh BadraouiMejdi Snoussi
Oct 31, 2020·Technology in Cancer Research & Treatment·Xinzhou DengZhiguo Luo
Nov 15, 2020·Pharmaceutics·Milad AshrafizadehAlan Prem Kumar
Jan 27, 2021·Environmental Toxicology·Mahdieh Farhoudi Sefidan JadidBehzad Baradaran
Jan 29, 2021·Environmental Toxicology·Mahdieh Farhoudi Sefidan JadidDariush Shanehbandi
Mar 7, 2021·Pharmaceuticals·Mehmet Abdullah AlagözBijo Mathew
Jun 27, 2021·Phytotherapy Research : PTR·Korosh MorshediHamed Mirzaei
Aug 7, 2021·Tissue & Cell·Samaneh AbbasiFatemeh Firouzi Amoodizaj
Oct 15, 2021·Journal of Receptor and Signal Transduction Research·Hassan GhasemiSaeed Mohammadi